Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins

Journal of the American Chemical Society

Volumn 110, Issue 18, 1988, Pages 5959-5967

  Cramer, Richard D ^a   Patterson, David E ^a   Bunce, Jeffrey D ^a  

^a Tripos International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CORTICOSTEROID; ESTROGEN; ETIOCHOLANONE; GESTAGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRANSCORTIN;

DRUG PROTEIN BINDING; METHODOLOGY; NONHUMAN; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY;

EID: 0023751431     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja00226a005     Document Type: Article

References (24)

1. Martin, Y. C. Quantitative Drug Design; Marcel Dekker: New York, 1978.
2. Burkert, U.; Allinger, N. L. Molecular Mechanics; American Chemical Society: Washington, DC, 1982.
3. Wold, S.; Ruhe, A.; Wold, H.; Dunn, W. J., III Siam J. Sci. Stat. Comput. 1984, 5, 735.
4. Simon, Z.; Badileuscu, I.; Racovitan, T. J. Theor. Biol. 1977, 66, 485. Simon, Z.; Dragomir, N.; Plauchithiu, M. G.; Holban, S.; Glatt, H.; Kerek, F. Eur. J. Med. Chem. 1980, 15, 521.
5. Hopfinger, A. J. J. Am. Chem. Soc. 1980, 102, 7196.
6. Ghose, A. K.; Crippen, G. M. J. Med. Chem. 1985, 28, 333 and references therein.
7. Cramer, R. D., III; Milne, M. Abstracts of the ACS Meeting, April 1979, COMP 44. Wise, M.; Cramer, R. D.; Smith, D. M.; Exman, I. In Quantitative Approaches to Drug Design; Dearden, J. C., Ed.; Elsevier: Amsterdam, 1983; p 145. Wise, M. in Molecular Graphics and Drug Design; Burgen, A. S. V., Roberts, G. C. K., Tute, M. S., Elsevier: New York, 1986; pp 183-194. Cramer, R. D., Ill; Bunce, J. D. In QSAR in Drug Design and Toxicology; Hadzi, D., Jerman-Blazic, B., Eds.; Elsevier: New York, 1987; P 3.
8. Goodford, P. J. J. Med. Chem. 1985, 28, 849.
9. Hansch, C.; Hathaway, B. A.; Guo, Z. R.; Selassie, C. D.; Dietrich, S. W.; Blaney, J. M.; Langridge, R.; Volz, K. W.; Kaufman, B. T. J. Med. Chem. 1984, 27, 129.
10. Dunn, J. F.; Nisula, B. C.; Rodbard, D. J. Clin. Endocrin. Metab. 1981, 63.
11. Cramer, R. D., III Quant. Struct. Act. Pharmacol., Chem. Biol. 1983, 2, 7, 13. Yunger, L. M.; Cramer, R. D., Ill Quant. Struc. Act. Relat. Pharmacol., Chem. Biol. 1983, 2, 149.
12. Westphal, U. Steroid-Protein Interactions II; Springer-Verlag: Berlin, 1986.
13. Vinter, J. G.; Davis, A.; Saunder, M. R. J. Comp.-Aided Mol. Design 1987, 1, 31.
14. Gasteiger, J.; Marsili, M. Tetrahedron 1980, 36, 3219.
15. Lindberg, W.; Persson, J.-A.; Wold, S. Anal. Chem. 1983, 55, 643
16. Cramer, R. D., III; Bunce, J. D.; Patterson, D. E.; Frank, I. E. Quant. Struct.-Act. Relat. Pharmacol., Chem. Biol. 1988, 7, 18.
17. Hopfinger, A. J. J. Med. Chem. 1983, 26, 990.
18. Mickelson, K. E.; Forsthoefel, J.; Westphal, U. Biochemistry 1981, 20, 6211.
19. Wold, S. Technometrics 1978, 20, 397. For a philosophical exposition of this and the related bootstrapping technique, see Diaconis, P.; Efron, B. Sci. Am. 1984, 116.
20. The results shown in the bottom line of Table I have recently been verified by Y. C. Martin and T. Lin of Abbott Laboratories, using our model coordinates, probe interaction energies calculated by Goodford's GRID program (ref 8), and their own implementation of PLS.
21. Stouch, T. R.; Jurs, P. C. J. Med. Chem. 1986, 29, 2125 and references therein.
22. Lybrand, T.; McCammon, J. A.; Wipff, G, Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 833. Bash, P. A.; Singh, U. C; Langridge, R.; Kollman, P. A. Science 1987, 236, 564.
23. Marshall, G. R.; Motoc, I. In Molecular Graphics and Drug Design; Burgen, A. S. V., Roberts, G. C. K., Tute, M. S., Eds.; Elsevier: New York, 1986; pp 117–156.
24. Mayer, D.; Naylor, C. B.; Cramer, R. D., III; Marshall, G. R., manuscript in preparation.